OptiGene Limited provides advanced molecular diagnostics solutions for applications across a range of market sectors. The company is based in Horsham, West Sussex, UK. OptiGene was established with the primary goal of providing the highest quality instrumentation and performance-leading reagents to support isothermal amplification of DNA and RNA. The market pull for this venture came from the growing demands around the world for field testing, rapid results, and point-of-care diagnostics.
OptiGene has developed innovative products that support sensitive and specific detection of bacteria and viruses for use in the fields of plant health, food safety, veterinary medicine, environmental monitoring and healthcare. Bio-defense and forensics are also key markets that OptiGene addresses, through its growing network of international distributors. The company has exploited its expertise in both instrument design and enzymology to develop a sophisticated open platform that will support all isothermal amplification methods. Ultra-sensitive molecular detection that has been constrained to laboratory use by highly-qualified personnel and taking hours to complete can now be deployed to point of application and run with very little training, producing results in single minutes.
S2 Threat Detection Technologies is the innovator of the revolutionary DETK Explosive Test Kit and the new LETK Liquid Explosive Test Kit for identifying hazardous materials. Both kits provide affordable, compact, robust, and comprehensive solutions to explosive detection.
Launched in January of 2014, S2 Threat Detection Technologies kits are already in use on a daily basis in over 350 international airports. Many experts consider the kits a disruptive technology due to the low cost, portability, and unprecedented accuracy.
S2 Threat Detection Technologies founders have strong track records in chemical research and development, as well as anti-terrorism and explosives threat detection and assessment for government and private groups worldwide.